Владимир Викторович Илюха

Владимир Викторович Илюха

Auto-generated profile, based on publicly available information

Владимир Викторович Илюха

Петрозаводский государственный университет

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
BLBridget Larkin
Bridget Larkin
VIVladimir Ilyukha
Vladimir Ilyukha
MSMaxim Sorokin
Maxim Sorokin
ABAnton Buzdin
Anton Buzdin
EVEdouard Vannier
Edouard Vannier
APAlexander Poltorak
Alexander Poltorak
Stimulator of interferon genes (STING) was initially described as a sensor of intracellular bacterial and viral DNA and a promising adjuvant target in innate immune cells; more recently STING has also been shown to detect endogenous DNA and play a role in tumor immunity and autoimmune disease development. Thus far STING has been studied in macrophages and dendritic cells. In this study, to our knowledge we provide the first evidence of STING activation in T cells, in which STING agonists not only provoke type I IFN production and IFN-stimulated gene expression, mirroring the response of innate cells, but are also capable of activating cell stress and death pathways. Our results suggest a re-evaluation of STING agonist–based therapies may be necessary to identify the possible effects on the T cell compartment. Conversely, the effects of STING on T cells could potentially be harnessed for therapeutic applications.

4 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HMHayley I. Muendlein
Hayley I. Muendlein
WCWilson M. Connolly
Wilson M. Connolly
ZMZoie Magri
Zoie Magri
ISIrina Smirnova
Irina Smirnova
VIVladimir Ilyukha
Vladimir Ilyukha
APAlexander Poltorak
Alexander Poltorak
Inflammation and cell death are closely linked arms of the host immune response to infection, which when carefully balanced ensure host survival. One example of this balance is the tightly regulated transition from TNFR1-associated pro-inflammatory complex I to pro-death complex II. By contrast, here we show that a TRIF-dependent complex containing FADD, RIPK1 and caspase-8 (that we have termed the TRIFosome) mediates cell death in response to Yersinia pseudotuberculosis and LPS. Furthermore, we show that constitutive binding between ZBP1 and RIPK1 is essential for the initiation of TRIFosome interactions, caspase-8-mediated cell death and inflammasome activation, thus positioning ZBP1 as an effector of cell death in the context of bacterial blockade of pro-inflammatory signaling. Additionally, our findings offer an alternative to the TNFR1-dependent model of complex II assembly, by demonstrating pro-death complex formation reliant on TRIF signaling.

1 December 2023 in Moscow University Biological Sciences Bulletin
Verified
Journal Article
Closed access
PDF file
AKAleksandra Kizhina
Aleksandra Kizhina
MMM. S. Maschinskas
M. S. Maschinskas
EPE. V. Panova
E. V. Panova
VIV. V. Ilyukha
V. V. Ilyukha
The effect of stevia leaf extract, saccharinate, and cyclamate in various dosages on the glycogen content of blood leukocytes in C57BL/6 mice as a necessar

8 March 2024 in Vestnik Moskovskogo universiteta. Seria 16. Biologia
Verified
Journal Article
Open access
PDF file
AKAleksandra Kizhina
Aleksandra Kizhina
MMM.S. Mashinskas
M.S. Mashinskas
EPE.V. Panova
E.V. Panova
VIV.V. Ilyukha
V.V. Ilyukha
We studied the eff ect of stevia leaf extract, saccharinate and cyclamate in various dosages on the glycogen content of blood leukocytes in mice, as a necessary substrate for the realization of phagocytosis. An increase of glycogen content was found in all experimental groups which obtained sweeteners at a dosage of 10 mg/g of body weight. The eff ect of sweeteners on the diff erential leukocyte counts was found only for mice treated with stevia leaf extract at a dosage of 10 mg/g of body weight. They demonstrated increase of neutrophil-to-lymphocyte ratio. New data expand our understanding of the metabolism of sugar substitutes in the organism and their eff ect on physiological systems, in particular the hematopoietic and immune systems.

16 April 2024 in ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»
Verified
Journal Article
Open access
PDF file
ЭПЭлина Валерьевна Панова
Элина Валерьевна Панова
НЗНаталья Сергеевна Зыкина
Наталья Сергеевна Зыкина
ВИВладимир Викторович Илюха
Владимир Викторович Илюха
Цель исследования – изучение влияния хронического употребления экстракта листьев стевии (ЭЛС, Stevia rebaudiana Bertoni), широко применяемой как сахарозаменитель, на биохимические показатели крови и состояние внутренних органов половозрелых самок мышей (Mus musculus domesticus) линии C57BL/6. Методика. Животные были разделены на 3 группы: контрольную и 2 опытных, получавших водный раствор экстракта листьев стевии по 1 (допустимая суточная доза – ДСД) и 10 мг/г массы тела соответственно в течение 2-х мес. Результаты. Показано повышение общего холестерина, снижение триацилглицеридов (ТАГ) и глюкозы крови, без дозозависимого эффекта. Установлено снижение массы поджелудочной железы и печени, а также сердца исключительно в группе получавшей ДСД экстракта. В этой же группе наблюдалось увеличение массы почек и селезенки. Кроме того прием экстракта приводил к изменению цвета почек, селезенки и печени, а в некоторых случаях к гидронефротическим изменениям почек. Заключение. Таким образом, хроническое употребление ЭЛС оказывает как положительный, так и отрицательный эффект, что обуславливает необходимость более точного определения ДСД экстракта. Aim: To study the effect of chronic treatment with stevia (Stevia rebaudiana Bertoni) leaf extract (SLE), that is widely used as a sweetener, on blood biochemistry and the state of internal organs in sexually mature C57BL/6 female mice (Mus musculus domesticus). Methods. Animals were divided into three groups: a control group and two experimental groups. The mice received a SLE water solution at doses of one (permissible daily dose, PDD) and 10 mg/g of body weight, respectively, for two months. Results. The study showed an increase in total cholesterol and decreases in triacylglycerols and blood glucose without a dose-dependent effect. Decreases in the weight of the pancreas, liver, and heart were observed only in the group receiving the SLE at PDD. In the same group, increases in the weight of the kidneys and spleen were observed. Also, the SLE treatment resulted in discoloration of the kidneys, spleen and liver, and, in some cases, hydronephrotic changes in the kidneys. Conclusion. Thus, the chronic treatment with the SLE had both positive and negative effects, which necessitates a more accurate determination of the SLE PDD.